Amplexa Genetics A/S’ Post

Thinking about offering your parients carrier screening for reproductive risk? It’s a key step to help make informed decisions about reproductive options. This webinar from Blueprint Genetics will review reproductive or expanded carrier screening, how to choose the right test, and important considerations for pre- and post-test counselling. The goal is to support in making empowered decisions for future families. Learn more here: https://lnkd.in/g6RbCnB4 🌿 #ReproductiveHealth #CarrierScreening #Genetics #FamilyPlanning

🌿 Thinking about carrier screening for reproductive risk? It’s a key step to help make informed decisions about reproductive options. Check out this webinar from Blueprint Genetics to explore the benefits of screening, how to choose the right test, and important considerations for pre- and post-test counselling. The goal is to support in making empowered decisions for future families. Learn more here: https://lnkd.in/g6RbCnB4 🌿 #ReproductiveHealth #CarrierScreening #Genetics #FamilyPlanning

🫶 We’re thrilled to announce an exciting new opportunity for professionals in the field of reproductive health! The SIG Reproductive Genetics is launching a new webinar series! 🚀 #FeRGI (Female Reproductive Genetics Initiative) brings together MAR professionals dedicated to enhancing expertise and patient care in female infertility by educating on recent developments and providing best practice guidelines. This series will introduce advanced genetic tests to help identify the causes of monogenic female infertility, guide you in choosing the right tests at the right time and walk you through the gene panel design process. We'll also discuss available treatment options for patients with causative genetic variants. 🎙️ Stephane Viville, Alberto Sola Leyva and Willem M.J. Verpoest kick start the first of two Webinar series. Webinar 1: Genetic testing for female infertility: how, when and for whom 📆 Thursday, 5 December - 17:00 CET Stay ahead with the latest advancements in MAR and register now: 🔗https://lnkd.in/e5mPKsSf #ESHRE #Webinars #SIGReproductiveGenetics #DataCurationProcess

Evolution of Genetic Testing in Reproductive Medicine In a recent podcast, I met with Dr. Joe Leigh Simpson, a distinguished figure in Reproductive Medicine, Obstetrics, Gynecology, and Genetics, discussed the transformative journey of in vitro fertilization (IVF) and the groundbreaking advancements in genetic testing that have revolutionized reproductive care. Dr. Simpson, with a prolific career marked by over 800 articles and leadership roles at prestigious universities, highlighted the significant shift from traditional protein-based screening to DNA-based analysis. The conversation delved into the Human Genome Project's role in decoding the intricacies of our DNA and its impact on genetic diagnosis. The discussion began with a historical perspective on prenatal genetic diagnosis, emphasizing the challenges before the Human Genome Project. Dr. Simpson recalled the pioneering techniques of amniocentesis and chorionic villus sampling, which allowed the examination of fetal cells for genetic abnormalities. However, the real game-changer emerged with the completion of the Human Genome Project, heralding an era where entire genomes could be sequenced efficiently. Dr. Simpson explained that, with advancements in technology, screening for thousands of genes became as economically feasible as targeting specific disorders. The conversation then shifted to the current capabilities of genetic testing, where neonatal blood samples can be rapidly analyzed to identify genetic mutations. This modern approach enables quick diagnoses for infants with severe medical issues, offering insights into potential genetic causes. Dr. Simpson emphasized that this comprehensive screening is not limited to specific disorders but covers the entire genome, providing a holistic view of potential genetic issues. This progress allows couples to seek genetic testing before conception, not only for fertility concerns but to mitigate the risk of passing on severe genetic conditions to their offspring. The podcast underscored the profound impact of genetic testing on reproductive medicine, transcending traditional infertility treatments. Couples can now make informed decisions about their family planning journey, focusing not only on conception but also on ensuring the health and well-being of future generations. Dr. Joe Leigh Simpson's insights shed light on the remarkable evolution of genetic testing, reshaping the landscape of reproductive healthcare. #genetictesting #genetics #humangenetics

Dive into the future of Reproductive Health! Join us for our Masterclass 2024 on July 31st, 1 PM SGT. Discover how next-gen sequencing is transforming the field with rapid, precise genetic variant identification. Don't miss out—register now to watch live! #ReproductiveHealth #NGS #GeneticVariants #Webinar #thermofisheremp

This article explores the ambiguous definition of a “serious” genetic condition in prenatal testing, advocating for a common understanding to enhance decision-making in reproductive genetics. #Genetics #PrenatalTesting #ReproductiveHealth #HealthcarePolicy #GMDPacademy #MedicalAffairs #MedicinesDevelopment #MedDevNews https://bit.ly/3YhNgbf

Introducing the industry’s first, Donor Output Index (DOI) developed by STgenetics to assist dairy breeders in improving donor performance. STgenetics DOI helps identify the highest genetic females to use as donors in an IVF program. A successful IVF/MOET program will allow producers to rapidly accelerate genetic gain in their herd as well as potentially add profit through embryo sales. Focusing on reproductive genomic evaluations through STgenetics Vision+™ genomic test will allow producers to specifically identify genetic potential for favorable donor traits. To learn more about STgenetics Donor Output Index, visit: https://lnkd.in/d3spk85D #STgenetics #DOI #DonorOutputIndex #IVF #DonorCows #Vision+ #GenomicTest #ReproductiveTraits #IntegratedApproach

To transfer or not to transfer? The dilemma of mosaic embryos is discussed in this new narrative review by Elkin Muñoz, Fernando Bronet, Belen Lledó, Gabriela Palacios Verdu, Lorena Martinez-Rocca, Signe Altmäe, and Josep Pla, representing the Special Interest Group in Reproductive Genetics of the Spanish Society of Fertility. The review summarizes current knowledge about mosaic embryos in the field of assisted reproduction techniques, and is intended to serve as reference material for practitioners in reproductive medicine who must manage a mosaic embryo result after preimplantation genetic testing for aneuploidies. Based on the assessment of current evidence in this paper, the authors suggest that embryos with a result within the mosaic range should not systematically be discarded or disregarded for transfer as this practice could negatively affect the cumulative live birth rate per cycle. All review articles in RBMO are made free to access. Read the full paper in our In-Press section now https://lnkd.in/euDz3pPa   #ClinicalAssistedReproductiveTechnology #NarrativeReview #LiteratureReview #GeneticCounselling #HumanEmbryonicMosaicism #Next-GenerationSequencing #PreimplantationGeneticTesting #ReproductiveOutcome

Do you have patients who need information about SMA? We have an entry to share with them, in our SMA Resource Center. Common questions, answered by genetic counselors https://lnkd.in/expBJVnY #genetictesting #spinalmuscularatrophy #obstetrics

The countdown has begun! Just two weeks left until we 'Spill the Tea on Fertility'. Join Adele Kazilsky on May 26th for an informative talk on the future of Reproductive Genetics. Don't miss out on the exclusive Q&A session with leaders in the field: CEO Adele Kazilsky and Medical Director Quintin Goodyear. Get your questions ready! #genetics #genetictesting #ivf